Bulevirtide for chronic hepatitis D: phase III data

Nat Rev Gastroenterol Hepatol. 2023 Sep;20(9):559. doi: 10.1038/s41575-023-00834-8.
No abstract available

Publication types

  • Clinical Trial, Phase III

MeSH terms

  • Antiviral Agents / therapeutic use
  • Hepatitis B virus
  • Hepatitis D, Chronic* / drug therapy
  • Hepatitis Delta Virus
  • Humans
  • Lipopeptides

Substances

  • Antiviral Agents
  • bulevirtide
  • Lipopeptides